Defining the Molecular Dysregulation in the Down Syndrome Neocortex
Displaying until May 14, 2025
Thursday, May 15 from 11:10-12:00 at 007-0001 (ATL). Dr. de la Torre-Ubieta studies human brain development using bioinformatics and genomic engineering. He aims to gain insights into the genetic, cellular, and molecular mechanisms that drive this process to develop new treatments for neurodevelopmental and neuropsychiatric conditions, such as autism and schizophrenia. This lecture will present recent findings into the cellular, molecular, and gene-regulatory disruptions during development in the Down Syndrome neocortex, leveraging single-cell genomics.